Related Experiment Video
Updated: May 13, 2025
Transplantation of Zebrafish Pediatric Brain Tumors into Immune-competent Hosts for Long-term Study of Tumor Cell Behavior and Drug Response
Published on: May 17, 2017
Developing a zebrafish xenograft model of diffuse midline glioma
Abstract:
Diffuse midline glioma (DMG) is a highly aggressive brain tumor that predominantly affects children. Conventional treatments such as radiation therapy can control progression for a time, but DMG kills nearly 100 percent of patients. Although murine models have provided critical insights into the biology of DMG and in assessing new therapeutic strategies, they are not suitable for high-throughput screening to identify and profile novel therapies due to technical challenges, ethical considerations and high cost. Zebrafish ( Danio rerio ) is an established vertebrate model for large-scale drug screening, and zebrafish have demonstrated the ability to replicate the key biological and pathlogical aspects of human malignancies. Here, we developed a novel method for transplanting human DMG cells into large numbers of zebrafish embyros to speed the assessment of anti-tumor drug efficacy in vivo and thereby facilitate the development of novel therapeutics for clinical translation. We transplanted red fluorescent protein (RFP)-labeled, patient-derived DMG cell lines into zebrafish blastulas. Remarkably, many DMG cells migrate into the developing brain and are present in the midline of the brain 24 hours after blastula injection. Tumor cell burden was monitored by measuring RFP fluorescence intensity changes over time. Time-course images of transplanted tumor cell volumes were acquired, and the interactions between transplanted DMG cells and microglial cells were further analyzed using Imaris software. We have developed a simple and rapid transplantation protocol to establish a zebrafish xenograft model of DMG. Our method involves transplanting DMG cells into the blastula stage (1000 cell stage) of zebrafish embryos, which does not require complex surgical techniques. This approach allows for the transplantation of hundreds of embryos per hour, significantly increasing the efficiency of creating DMG zebrafish xenografts that are suitable for high-throughput drug and gene discovery screens.
Insights
Researchers developed a novel zebrafish xenograft model for diffuse midline glioma (DMG). This high-throughput screening method accelerates the discovery of new anti-cancer drugs for this aggressive pediatric brain tumor.
Area of Science:
- Oncology
- Genetics
- Developmental Biology
Background:
- Diffuse midline glioma (DMG) is an aggressive pediatric brain tumor with a near 100% mortality rate.
- Current treatments offer limited efficacy, and existing murine models are unsuitable for high-throughput drug screening.
- Zebrafish (Danio rerio) offer a promising vertebrate model for large-scale drug screening due to their biological relevance and amenability to high-throughput methods.
Purpose of the Study:
- To develop a novel, efficient zebrafish xenograft model for diffuse midline glioma (DMG).
- To facilitate high-throughput screening of potential anti-tumor drugs for DMG.
- To accelerate the development of novel therapeutics for clinical translation.
Main Methods:
- Patient-derived, red fluorescent protein (RFP)-labeled DMG cell lines were transplanted into zebrafish blastulas.
- Tumor cell burden was monitored non-invasively by measuring RFP fluorescence intensity over time.
- Tumor cell migration, growth, and interactions with host cells were analyzed using imaging software.
Main Results:
- DMG cells successfully engrafted and migrated to the midline of the zebrafish brain post-transplantation.
- The developed protocol is simple, rapid, and allows for high-throughput transplantation of hundreds of embryos per hour.
- This method establishes a functional zebrafish xenograft model suitable for drug and gene discovery screens.
Conclusions:
- A novel and efficient zebrafish xenograft model for diffuse midline glioma (DMG) has been established.
- This model system significantly enhances the capacity for high-throughput screening of anti-cancer therapeutics.
- The developed method holds promise for accelerating the discovery of effective treatments for pediatric DMG.
